Leprosy Mailing List – December 21 , 2014
Ref.: (LML) Announcement Leprosy Research Initiative: deadline for submission of Letter of Intent
From: Nicole Dinnissen, NLR, Amsterdam, The Netherlands
Dear all,
The Leprosy Research Initiative (LRI) is a combined venture of the Netherlands Leprosy Relief (NLR), American Leprosy Missions (ALM), German Leprosy and Tuberculosis Relief Association (GLRA) and The Leprosy Mission Canada (TLMC). Guided by an allied policy with clearly defined research priorities, the four partners have established a joint fund to support leprosy research. The joint fund will be reserved for research that is exclusively or strongly related to leprosy. Additional resources will be actively sought for research in the field of general disabilities and for research aimed at different diseases (e.g. other NTDs, TB and diabetes) in combination with leprosy.
Researchers interested to apply for funding by the LRI are invited to complete and submit a Letter of Intent (LoI), giving an outline of the intended research. The LoI should use the format provided on the LRI website (www.leprosyresearch.org ). Applications that do not follow this format will not be considered.
A Letter of Intent may be submitted at any time during the year. However, to be considered for the budget round 2016, LoIs should be submitted by April 1st, 2015 by e-mail to the LRI Secretariat, c/o Ms. Nicole Dinnissen (info@leprosyresearch.org ). This letter will be screened by the LRI Steering Committee (SC). If the feedback by the SC is positive, the applicants will be invited to submit a full proposal before the next deadline (June 1st).
With kind regards,
Nicole Dinnissen
Leprosy Research Initiative (LRI)
c/o Netherlands Leprosy Relief
Postbus / P.O. Box 95005
1090 HA Amsterdam
The Netherlands
Tel: | +31 20 5950534 |
Email: | |
Web: | |
LML - S Deepak, B Naafs, S Noto and P Schreuder
LML blog link: http://leprosymailinglist.blogspot.it/
Contact: Dr Pieter Schreuder << editorlml@gmail.com
 | This email has been checked for viruses by Avast antivirus software. |
No comments:
Post a Comment